
Underused menopausal therapy linked to deadly UTI toll in older women
A USA TODAY investigation shows vaginal estrogen—a safe, inexpensive treatment to prevent recurrent urinary tract infections in menopausal women—can substantially lower hospitalizations, sepsis, and death, yet its use remains around 10% among Medicare patients due to decades of FDA warnings, training gaps, and cost barriers, contributing to preventable suffering and deaths like Roselin Shankland’s.












